Given that modulation of the ABC transporters might influence the pharmacokinetics of other co-administered chemotherapeutic drugs, more care should be taken upon the combination of retinoids with other anti-cancer drugs to avoid drug–drug interactions occurring at the level of the membrane transporters, P-gp and BCRP. The gene discussed is ABCG2; the disease is cancer.